James Hartley. Aberrant Splicing Factor SF3A2 As a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay With Immune Infiltration and Natural Product Intervention. ijmsdh 2026, 12 (09), 176-181. https://doi.org/10.55640/ijmsdh-12-09-20.